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Abstract
Women who inject drugs are disproportionately affected by HIV and intimate partner violence (IPV); however, the link 
between IPV and HIV remains under-researched among substance-using women in low- and middle-income countries. This 
study examined associations and additive effects of different forms of IPV victimization (psychological, physical and/or 
injurious, and sexual) on HIV sexual risk behavior among women who inject drugs in Indonesia. Respondent-driven sam-
pling (RDS) was used to recruit 731 women from Greater Jakarta and Bandung, West Java. RDS-II weighted prevalence of 
any past-year IPV was 68.9% (95% CI 65.0, 72.6) in Jakarta and 55.9% (95% CI 48.0, 63.5) in Bandung. In separate logistic 
regressions controlling for socio-demographic covariates, all three forms of IPV showed statistically significant associa-
tions with sexual risk behavior. After adjusting for all IPV types, psychological (OR 1.87; 95% CI 1.17, 2.99; p = 0.009) and 
sexual (OR 1.98; 95% CI 1.22, 3.21; p = 0.006) IPV independently predicted women’s sexual risk behavior. Marginal effects 
models suggested that co-occurrence of multiple forms of IPV had greater adverse consequences: sexual risk behavior was 
reported by 64.1% of women who did not experience any IPV, but increased to 89.9% among women exposed to all three 
types. Comprehensive harm reduction services that integrate IPV monitoring and prevention are urgently needed to reduce 
both HIV and IPV.
Keywords Intimate partner violence · HIV · Sexual risk behavior · Women · Injecting drug use · Respondent-driven 
sampling
Resumen
Las mujeres que se inyectan drogas se ven desproporcionadamente afectadas por el VIH y la violencia de pareja (IPV); sin 
embargo, el vínculo entre la IPV y el VIH sigue siendo poco investigado entre las mujeres que usan sustancias en países de 
bajos y medianos ingresos. Este estudio examinó las asociaciones y los efectos aditivos de las diferentes formas de victimi-
zación por IPV (psicológica, física y/o perjudicial y sexual) en el comportamiento de riesgo sexual del VIH entre las mujeres 
que se inyectan drogas en Indonesia. Se utilizó el muestreo dirigido por el encuestado (RDS) para reclutar a 731 mujeres 
del Gran Yakarta y Bandung, Java Occidental. La prevalencia ponderada de RDS-II de cualquier IPV de años anteriores fue 
de 68.9% (IC 95% 65.0, 72.6) en Yakarta y 55.9% (IC 95% 48.0, 63.5) en Bandung. En regresiones logísticas separadas que 
controlan las covariables sociodemográficas, las tres formas de IPV mostraron asociaciones estadísticamente significativas 
con el comportamiento de riesgo sexual. Después de ajustar para todos los tipos de IPV, psicológico (OR 1.87, IC 95% 1.17, 
2.99, p = 0.009) y sexual (OR 1.98, IC 95% 1.22, 3.21, p = 0.006) IPV predijo de forma independiente el riesgo sexual de las 
mujeres comportamiento. Los modelos de efectos marginales sugirieron que la concurrencia de múltiples formas de IPV tuvo 
mayores consecuencias adversas: el 64.1% de las mujeres que no experimentaron ninguna IPV informaron el comportamiento 
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de riesgo sexual, pero aumentó al 89.9% entre las mujeres expuestas a los tres tipos. Se necesitan con urgencia servicios 
integrales de reducción de daños que integren el monitoreo y prevención de IPV.
Introduction
Asia is home to half of the estimated 3.8 million women 
who inject drugs globally [1]. Meta-analytic evidence 
has established that women who inject drugs experience 
higher levels of HIV than their male counterparts in high 
prevalence settings [2]. At the same time, there is growing 
recognition that social and structural factors shape indi-
vidual risks and increase vulnerability to HIV via direct 
and indirect pathways [3, 4]. Intimate partner violence 
(IPV) has been highlighted as a key contributor to HIV 
transmission risk among drug-using women [5]. IPV is 
also more prevalent among women who inject drugs vis-à-
vis women in the general population. For example, a recent 
review identified rates of past-year IPV ranging from 20% 
to 57% among clinical and community-based samples of 
women who use drugs in the United States, which is 2–5 
times higher than prevalence rates found among general 
female populations [6, 7].
In North America, IPV victimization against women 
who inject drugs has been associated with the presence of 
multiple risk factors for sexually-transmitted HIV, includ-
ing condomless sex, multiple sexual partners, history of 
past or current sexually transmitted infections (STIs), 
and trading sex for money, drugs, or shelter [8]. Differ-
ent forms of IPV (i.e. psychological, physical, and sexual) 
may increase women’s susceptibility to HIV risk through 
direct and indirect mechanisms. Sexual IPV or forced sex 
may directly exacerbate women’s HIV risk through biolog-
ical mechanisms, via genital injuries and lacerations that 
facilitate disease transmission [9]. Indirectly, both sexual 
and physical IPV have been shown to impact HIV risk by 
creating a dynamic of fear and submission that hinders 
a woman’s ability to negotiate safer sex [5]. Psychologi-
cal abuse may create a similar context of dominance and 
control, which increases women’s likelihood of engaging 
in risky sexual behaviors [10]. In fact, emerging research 
suggests that psychological aggression has similar detri-
mental effects on women’s health outcomes to physical and 
sexual forms of IPV [11, 12].
A growing body of international research has docu-
mented strong associations between IPV and HIV, both 
in the general population [13] and among key popula-
tions such as men who have sex with men and female sex 
workers [14]. However, extant research investigating this 
association among drug-involved women is geographically 
clustered in high-income countries [5, 15, 16]. Crucially, 
no published research to date has explored this relation-
ship among women who inject drugs in low- and middle-
income countries in Asia.
In contrast with a trend of stabilisation across most 
countries in the Asia region, Indonesia is facing an esca-
lating HIV epidemic concentrated among key popula-
tions [17]. With an HIV prevalence of 36.4%, people who 
inject drugs remain disproportionally affected compared 
with other key populations, such as female and transgen-
der sex workers and their clients, and men who have sex 
with men [18]. Despite their smaller numbers compared 
with their male counterparts, women who inject drugs face 
elevated vulnerability to HIV [19–21]. In 2009, the only 
year for which sex-disaggregated estimates are available, 
HIV prevalence among women who inject drugs in Indo-
nesia was 57.1%, relative to 52.1% among male injectors 
[22]. Furthermore, qualitative studies from urban settings 
across the Indonesian archipelago suggest that IPV and 
HIV vulnerability may co-occur among women who use 
and inject drugs [19, 20, 23–25]. For instance, in a multi-
city qualitative study of 52 women who use drugs, Habsari 
et al. identified pervasive exposure to violence perpetrated 
by both intimate and non-intimate partners [19]. Women 
have also reported that in situations where they felt at risk 
of HIV infection whilst in an abusive relationship, their 
priority was not protection against HIV infection. Instead, 
women sought to avoid conflict out of fear of provoking 
aggression from their partners, and a desire to “maintain 
their relationship” [25]. However, no quantitative stud-
ies to date have explored the prevalence and associations 
of IPV and HIV sexual risk behavior among women who 
inject drugs in Indonesia.
Understanding the relationship between different forms 
of IPV and sexual risk behavior is essential for elucidating 
pathways to HIV and for informing effective interventions 
with women who inject drugs in low-and middle-income 
countries. There is a clear need for quantitative research 
with adequately sized samples and validated measures, to 
assess the effect of IPV on drug-using women’s HIV risk 
outcomes in Asia. Accordingly, this study examines the 
largest known sample of Indonesian women who inject 
drugs to date to investigate (1) associations between expo-
sure to psychological, physical and/or injurious, and sex-
ual dimensions of IPV and HIV sexual risk behavior; and 
(2) potential additive effects of IPV polyvictimization on 
women’s sexual risk behavior.
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Methods
Study Design and Sampling
A cross-sectional design was employed to recruit women who 
inject drugs from urban areas with large numbers of people 
who inject drugs and high HIV rates among injectors [26]: 
Jakarta and peri-urban surrounding cities Bogor, Tangerang, 
Depok and Bekasi (hereafter referred to as “Greater Jakarta”) 
and Bandung, the provincial capital of West Java. The mini-
mum sample size for this study (709 participants) was calcu-
lated by assuming a 36% HIV prevalence rate [18], with 95% 
confidence, 5% precision, and a design effect of 2 [27, 28].
The community of women who inject drugs was actively 
engaged in the development, implementation, and dissemina-
tion of the research. Four focus group discussions with a total 
of 39 women, and three consultations with relevant key popu-
lation networks and community-based organisations, were 
convened to ensure that all study procedures were sensitive to 
the needs of participants. A community advisory group com-
prised of six women with an injecting drug use background 
was established to advise researchers throughout study imple-
mentation. Once the data were analysed, a consultation was 
convened to discuss results with peers and devise strategies 
for dissemination.
Between September 2014 and June 2015, 731 women were 
recruited using respondent-driven sampling (RDS). RDS, a 
modified chain referral sampling method, is known to be effec-
tive for the recruitment of populations that are hard-to-reach 
[29]. Akin to snowball sampling, RDS utilizes peer networks 
to recruit participants. However, RDS limits the influence of 
recruiters on the final composition of the sample by restricting 
the number of recruits per recruiter, and weights the sample by 
participants’ probability of recruitment (social network size) 
to adjust for non-random sampling [30]. Since its introduction 
in 1997, over 460 RDS studies in 69 countries have been con-
ducted with hidden or hard-to-reach populations [31].
Eligibility criteria included: being ≥ 18 years of age; resid-
ing in one of the study catchment areas; injecting drugs in 
the preceding 12 months; and possessing a valid recruitment 
referral. Guided by the internationally-supported definition 
proposed by WHO, UNODC, and UNAIDS and by indica-
tors used in national surveillance [26, 32], this study deemed 
women reporting any instance of illicit or illegal drug injecting 
occurring in the previous 12 months as eligible [33].
Procedures
To initiate recruitment, a diverse group of 20 initial recruits 
(“seeds”) was selected by the researchers. Seed selection was 
informed by extensive formative research, including map-
ping of hotspots where people inject drugs, key informant 
interviews with local harm reduction service providers, and 
community consultations. To increase the representativeness 
of the sample, selected seeds were heterogeneous in terms of 
age, education, levels of risk behavior, and known HIV sta-
tus. Each initial recruit was asked to refer up to three peers 
to the study, who in turn enlisted others in a chain-referral 
fashion. Successive waves of recruitment continued until the 
desired sample size was reached.
Questionnaires were translated into Bahasa Indonesia by 
bilingual health workers and pre-tested with women rep-
resentative of the target sample according to WHO guide-
lines [34]. Seven female peer fieldworkers were trained by 
senior researchers in mobile-assisted interviewing, ethics, 
and health and safety. Face-to-face interviews lasted approx-
imately 1 h and were conducted in the local language at 
locations deemed safe by participants, such as offices of 
non-governmental organisations or participants’ homes. 
Information was collected using tablets equipped with Open 
Data Kit, an open-source application for data collection and 
management on mobile devices [35].
The study used mobile-site interviewing. Potential 
recruits were asked to contact the research team by phone 
or text message to set up an interview at a location of their 
choice. As part of the RDS process, participants received a 
primary incentive of 75,000 Indonesian Rupiah (~ USD $5) 
for participating in the interview and a secondary incentive 
of 25,000 Indonesian Rupiah (~ USD $2) per eligible peer 
recruited. Monetary remuneration is considered an ethical 
and effective way to facilitate participation in public health 
research by people who use drugs [36, 37]. Appropriate 
renumeration was determined by consulting the community 
advisory group and previous bio-behavioral surveys with 
people who inject drugs in Indonesia. Each recruit was given 
a uniquely coded identifier and recorded in SyrEx2, a moni-
toring and evaluation tool used by drug service providers 
[38].
Ethical Considerations
The study was anonymous, and all participants were encour-
aged to use a pseudonym. Verbal and written voluntary 
informed consent was obtained from each participant. Con-
sent forms were worded in plain language and included clear 
explanations of the nature and purpose of the research, lim-
its to confidentiality in the context of illegal activities, and 
explicit statements regarding participants’ rights to opt-out 
at any point. Consent forms were read and discussed verbally 
by the interviewers to ensure that participants had the nec-
essary information to be able to provide informed consent, 
regardless of literacy level.
Strict confidentiality was maintained, except where par-
ticipants requested assistance or service referrals. In the 
case that information disclosed suggested that a participant 
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was at risk of significant harm (e.g. severe violence) the 
interviewer discussed concerns with the participant and 
offered service referrals. Researchers maximised oppor-
tunities for referral by providing all participants with a 
local directory of HIV/STI testing and counselling, legal 
aid, and IPV support services. Interviewers explained to 
participants what existing services they could access for 
free and how to do so. Ethical protocols were approved by 
the ethics boards at the University of Oxford (ref no: SSD/
CUREC2/13-23) and Atma Jaya University (ref no: 1114/
III/LPPM-PM.10.05/11/2013).
Measurement
HIV Sexual Risk Behavior
HIV sexual risk behavior in the preceding 12 months was 
measured using items from the UNAIDS Global AIDS Pro-
gress Reporting Indicator Registry [39] and informed by 
WHO guidance [40]: (1) condomless sex at last vaginal and/
or anal intercourse; (2) multiple sexual partners; and (3) STI 
symptomatology. Sexually active participants were asked 
the following yes/no question, “Think about the last time 
you had vaginal and/or anal sex with any sexual partner. 
Did you use a condom the last time you had sex?” Partici-
pants who responded in the negative were coded as having 
had condomless sex at last intercourse (0 = used condom/not 
sexually active; 1 = did not use condom at last intercourse). 
Participants were also asked about the total number of sexual 
partners in the preceding 12 months. Following previous 
research [8, 41], multiple sexual partners was operational-
ized as having two or more sexual partners in the previous 
year. Condomless sex at last intercourse and multiple sexual 
partners included both steady and casual partners and paid 
and unpaid sex. STI symptomatology was assessed using a 
multiple-choice checklist of six easily recognised symptoms 
(i.e. “burning sensation and/or discomfort when urinating,” 
“itching, irritation and/or discomfort in the genital area,” 
“discomfort and/or pain during sexual intercourse,” “sores, 
blisters and/or ulcers on or in the vagina,” “unusual vaginal 
discharge, such as pus or a thick and/or sticky liquid from the 
genital area,” and/or “lower abdominal pain”) [40, 42]. STI 
symptomatology was ascertained if participants reported 
experiencing ≥ 2 symptoms.
A dichotomous variable reflecting women’s HIV sexual 
risk behavior during the preceding 12 months was created 
by coding one or more affirmative responses to the three 
items above as the presence of sexual risk behavior (0 = no 
sexual risk behavior, 1 = sexual risk behavior). Participants 
who did not endorse any of the three risk behaviors assessed 
and those who were not sexually-active were coded as 0 = no 
sexual risk behavior.
Intimate Partner Violence
Intimate partner violence was assessed using the psycho-
logical, physical, injurious, and sexual subscales of the 
Revised Conflict Tactics Scale (CTS2) short form [43, 44]. 
The CTS2 has been cross-culturally validated in more than 
17 countries, including several low- and middle-income 
countries in Asia [45], and is the most widely-used meas-
ure assessing IPV victimization in community and clinical 
samples of drug-using women [8, 41, 46]. Sample items 
from each of the subscales include: psychological aggres-
sion (“My partner insulted or swore or shouted or yelled at 
me”); physical assault (“My partner punched or kicked or 
beat-me-up”); injurious physical assault (“I went to see a 
doctor or needed to see a doctor because of a fight with my 
partner”); and sexual coercion (“My partner used force, like 
hitting, holding down, or using a weapon, to make me have 
sex”). Participants were asked about violence perpetrated 
by a current or former intimate partner in the preceding 
12 months. Guided by previous research [47, 48], binary 
variables were created for each type of IPV (psychological, 
physical and/or injurious, and sexual) by assigning a score 
of 1 if one or more instances of the items were reported to 
have occurred in the past year and 0 if no instances were 
reported. Affirmative responses to IPV victimization items 
on each subscale were coded as 1 regardless of responses to 
subscales for other IPV types. For this sample the CTS2 sub-
scales showed adequate to high internal consistency, ranging 
between α = 0.65 and α = 0.82, and totalling α = 0.87 for the 
full scale.
Sociodemographic and Background Characteristics
Informed by a literature review and formative research, 
selected socio-economic and background information was 
collected as the basis for a confounder analysis and potential 
effect modification [8, 20, 41, 49]. Using items modelled on 
the Indonesia Population Census (Statistics Indonesia) and 
Integrated Biological and Behavioral Surveillance (Ministry 
of Health), women were asked their age, relationship status, 
employment status, level of education, individual monthly 
income, and whether they had any dependent children in the 
household or other dependents for whom they were responsi-
ble. Individual monthly income was classified as being either 
below or above the mean national income in Indonesia [50]. 
Participants were also asked about illegal and/or illicit drug 
use in the previous 12 months, and whether they had knowl-
edge of their HIV status.
Since previous longitudinal research has established a 
link between drug-using women’s financial dependency 
on their intimate partner and elevated sexual risk behavior 
[51], a variable reflecting this construct was included as a 
potential confounder. Financial dependency was assessed by 
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asking participants about the main source (> 50%) of their 
monthly income. Women were coded as financially depend-
ent if they indicated that their main source of income was 
from intimate partner(s). Furthermore, studies have shown 
that the syndemic co-occurrence and interaction of multiple 
psychosocial factors may augment HIV risk-taking behavior 
[5, 52, 53]. In particular, as crystal meth has been shown 
to co-occur with IPV and heighten HIV risk [54, 55], a 
dichotomous variable was computed to indicate any past-
year use of non-injection crystal meth. Following previous 
research indicating that the relationship between IPV, other 
syndemic factors, and HIV risk may be modified by struc-
tural influences such as poverty and housing instability [56, 
57], a variable reflecting women’s housing status was also 
included. Housing status was assessed by asking participants 
about their current living arrangements and dichotomised 
into “stable housing” vs “unstable housing/homelessness”. 
Women were coded as “unstably housed and/or homeless” if 
they lived on the street, including in public spaces (i.e. train 
station) or in temporary or transitional accommodation, such 
as a friend’s home, and “stably housed” if they lived in their 
family home, rental house/apartment, and rental long-term 
single-room accommodation (kos-kosan). All measures were 
based on self-report.
Statistical Analysis
Analyses were conducted in four stages:
1. Frequencies for all variables were conducted on the 
unweighted, aggregated sample. RDS-II weighted esti-
mates of population proportions and 95% confidence 
intervals (CIs) and sample diagnostics were calculated 
using the user-written RDS analysis package [58, 59] in 
Stata 14 (StataCorp, College Station, TX). Preliminary 
analyses revealed that participants formed two isolated 
geographical components with minimal across-group 
recruitment (i.e. bottleneck), which can add variance 
to a sample and produce unstable estimates [60] (see 
Supplementary Appendix II). In the presence of bottle-
necks, standard practice in RDS literature is to produce 
estimates for each sub-sample individually rather than 
combining them into an overall sample [60]. Therefore, 
weighted estimates and RDS diagnostics for HIV sexual 
risk and IPV variables were computed separately for 
each study city. However, in order to retain the power 
and precision corresponding to the initial calculated 
sample size, and because city differences can be adjusted 
for, the unweighted city sub-samples were aggregated 
for subsequent bivariate and multivariate analyses.
2. Bivariate associations between IPV and background 
variables and the sexual risk behavior outcome were 
examined using logistic regressions. Variables associ-
ated with sexual risk behavior at p < 0.1 were retained 
in multivariate analyses [61].
3. To explore the independent effects of each IPV dimen-
sion from its overall effect, separate multivariate logistic 
regression models were created for each form of IPV 
(psychological, physical and/or injurious, and sexual), 
and a final model controlled for all IPV dimensions 
simultaneously. For robustness, we assessed potential 
multicollinearity between predictor variables using 
variance inflation factor (VIF) diagnostic tests, which 
quantify how much the variance of the estimated regres-
sion coefficient is inflated by the presence of correlation 
among the independent variables in the model [62, 63]. 
The presence of multicollinearity was defined as toler-
ance values below 0.1 and VIF values equal to or greater 
than 10 [62]. For models 1–3 assessing each IPV dimen-
sion separately, VIFs for all independent variables were 
lower than 4, mean VIFs for all models were under 2, 
and tolerance values ranged between 0.25 and 0.89. In 
model 4, which included all IPV dimensions, VIFs for 
predictor variables ranged between 1.14 and 4.10. The 
mean VIF for the entire model was 2.29, which is lower 
than the accepted threshold of 6, thus indicating accept-
able fit of the model. In addition, tolerance values for 
variables in model 4 were between 0.24 and 0.88, with 
no values falling below 0.1. Therefore, no evidence of 
multicollinearity was identified between the predictors 
analyzed in the present study. We also tested for plau-
sible two-way interactions between each dimension of 
IPV and background variables using product terms. No 
statistically significant interactions were detected.
4. We tested whether sexual risk behavior effects were 
greater if women experienced more than one form of 
IPV. All IPV variables that were included in model 4 
were entered into a marginal effects model, adjusting 
for significant confounders. Predicted probabilities of 
engaging in HIV sexual risk behavior under each poten-
tial combination of IPV exposures were computed, with 
significant covariates held at mean values.
Results
RDS Sample Characteristics
A total of 731 women who inject drugs were recruited into 
the study, using 18 seeds and 554 recruits in Greater Jakarta 
(n = 572) and 2 seeds and 157 recruits in Bandung (n = 159). 
Five seeds, two in Bandung and three in Greater Jakarta, 
generated 54% (n = 391) of the combined sample across 
the two survey cities. The largest recruitment chain reached 
up to 11 waves and contained 105 participants in Greater 
Jakarta, and 8 waves with 98 participants in Bandung. 
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Participants’ mean personal network size (degree) was 4.7 
(SD = 4.2, range 1–35) in Greater Jakarta, and 3.9 (SD = 2.0, 
range 1–21) in Bandung. No considerable differentials in 
mean degree were observed for any of the variables in this 
study.
An RDS sample attains equilibrium when the sample dis-
tribution on key variables remains stable (i.e. within 2% of 
cumulative sample proportions) as new recruits are added 
[64]. Convergence refers to the required referral chain length 
(i.e. depth) necessary to reach equilibrium [65]. To deter-
mine whether recruitment chains converged to a sampling 
equilibrium, convergence plots superimposing the weighted 
sample proportions at each recruitment wave on the cumula-
tive proportion based on the complete sample were exam-
ined for select variables (see Supplementary Appendix I) 
[66]. Proportions for this sample appear to stabilize between 
waves 3–5 for Bandung and waves 2–5 for Greater Jakarta 
and remain stable until the full sample size is attained, indi-
cating that the sample is becoming random as additional 
participants enroll.
Homophily assesses the extent to which participants pre-
fer to recruit those with similar characteristics to themselves 
rather than uniformly at random [64]. We used the homoph-
ily index (Hx) proposed by Heckathorn, which contains val-
ues ranging from − 1.0 to 1.0 [30]. Scores close to 0 indicate 
random recruitment and scores higher than 0.3 (or − 0.3) 
specify substantial in-group contact. Most analysis and out-
come variables showed low homophily (all Hx < 0.27), indi-
cating a high tendency to recruit others at random. Moder-
ate homophily was detected for sexual coercion (Hx = 0.35), 
such that women from Jakarta who did not experience past-
year sexual coercion tended to recruit others like themselves 
35% of the time and at random 65% of the time.
Sociodemographic and background characteristics
Mean age in the aggregated, unweighted sample was 
31.3 years (SD = 5.10 years) (Table 2). 20.2% of women 
completed less than a high school education, 38.7% were 
currently married, and 56.5% had children or other depend-
ents for whom they were responsible. Mean individual 
monthly income was IDR 4.3 million/USD 385 (SD = 3.38), 
with more than half (54.5%) of participants earning less than 
the average national income (IDR 3.8 million ~ USD 285). 
Nearly half of the women (44.3%) were unemployed, and 
at least one quarter (25.4%) were financially dependent on 
an intimate partner. 5.3% of the women were homeless or 
unstably housed.
Drugs injected in the previous year included heroin 
(94.4%), illicit buprenorphine (19.2%), illicit pharmaceu-
ticals (i.e. largely in the opiate and benzodiazepine class of 
substances, used without a prescription) (4.0%), and crystal 
methamphetamine (crystal meth) (0.8%). Drugs used via 
non-injection routes of administration, such as smoking, 
snorting, or swallowing, included heroin (93.8%), crystal 
meth (67.2%) illicit pharmaceuticals (46.2%), cannabis 
(36.3%), and ketamine (6.6%). Self-reported HIV prevalence 
in the sample was 46.7%.
Prevalence of Sexual Risk Behavior and Intimate 
Partner Violence
Overall, similar proportions of participants in Greater 
Jakarta (76.2%; 95% CI 71.4, 80.5) and Bandung (74.1%; 
95% CI 66.2, 80.6) reported one or more of three HIV sexual 
risk behaviors (i.e. condomless sex at last intercourse, STI 
symptomatology, or multiple sexual partners) (Table 1). The 
prevalence of condomless vaginal and/or anal sex at last 
intercourse ranged from 46.9% (95% CI 39.2, 54.8) in Band-
ung to 65.1% (95% CI 61.1, 68.8) in Greater Jakarta. The 
prevalence of STI symptomatology was higher in Greater 
Jakarta (52.8%; 95% CI 48.6, 56.8) relative to Bandung 
(21.2%; 95% CI 15.7, 28.1). However, a higher proportion 
of participants in Bandung reported having multiple sexual 
partners in the preceding year (37.8%; 95% CI 30.5, 45.7), 
compared with participants from Greater Jakarta (25.1%; 
95% CI 21.6, 28.9) (Table 2).
There were notable differences in the prevalence of IPV 
victimization across the two survey cities (Table 1). Bandung 
had a lower prevalence of any form of past-year IPV (55.9%; 
95% CI 48.0, 63.5) relative to Greater Jakarta (68.9%; 95% 
CI 65.0, 72.6). Participants in Greater Jakarta reported 
higher levels of psychological aggression (58.8%; 95% CI 
54.7, 62.8) as compared with those in Bandung (52.6%; 95% 
CI 44.7, 60.3). The prevalence of sexual coercion in Greater 
Jakarta (39.8%; 95% CI 35.7, 44.0) was nearly double that 
in Bandung (19.6%; 95% CI 13.7, 27.3). However, reported 
levels of physical and/or injurious assault were higher in 
Bandung (42.2%; 95% CI 34.8, 50.0) than in Greater Jakarta 
(38.8%; 95% CI 35.0, 42.8).
Bivariate Associations Between IPV and HIV Sexual 
Risk Behavior
There were significant positive associations in bivariate 
analyses between the sexual risk behavior outcome and 
each form of IPV (Table 3): psychological aggression (OR 
2.92, 95% CI 2.05, 4.16; p < 0.001), physical and/or inju-
rious assault (OR 2.73, 95% CI 1.87,3.98; p < 0.001), and 
sexual coercion (OR 2.38, 95% CI 1.54,3.66; p < 0.001). 
Additionally, there were statistically significant associa-
tions at p < 0.1 between sexual risk behavior and several 
background variables: crystal meth use (OR 2.47, 95% CI 
1.74,3.51; p < 0.001), HIV-positive status (OR 1.37, 95% CI 
0.97, 1.94; p = 0.074), lower than high school educational 
attainment (OR 2.59, 95% CI 1.53, 4.39; p < 0.001), being 
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currently married (OR 0.74, 95% CI 0.53, 1.05; p = 0.093), 
homelessness and/or unstable housing (OR 3.88, 95% CI 
1.18,12.75; p = 0.026), age (OR 0.95, 95% CI 0.91, 0.98; 
p = 0.002), and survey city (OR 1.50; 95% CI 1.01, 2.23; 
p = 0.044). These variables were thus retained in subsequent 
multivariate models.
Multivariate Associations Between IPV and HIV 
Sexual Risk Behavior
After adjusting for significant covariates, all three forms 
of IPV were associated with elevated odds of engaging in 
sexual risk behaviors (models 1–3, Table 4). Specifically, 
women who experienced psychological IPV were nearly 
three times more likely to engage in sexual risk behavior 
(OR 2.77; 95% CI 1.91, 4.03; p < 0.001) relative to women 
who did not experience such abuse. Furthermore, women 
exposed to physical and/or injurious IPV were at least twice 
more likely to engage in sexual risk behavior (OR 2.49; 95% 
CI 1.67, 3.70; p < 0.001) compared with women who were 
not exposed to physical and/or injurious IPV. Lastly, experi-
encing sexual IPV nearly tripled the odds of engaging in sex-
ual risk behavior (OR 2.61; 95% CI 1.65, 4.13; p < 0.001). 
There were statistically significant positive associations 
between engaging in sexual risk behavior and the following 
covariates in all three multivariate models: crystal meth use, 
HIV-positive status, younger age, lower than high school 
educational attainment, and not being currently married.
Model 4 (Table 4) included all dimensions of IPV and 
controlled for significant covariates. Psychological aggres-
sion (OR 1.87, 95% CI 1.17, 2.99; p = 0.009), and sexual 
IPV (OR 1.98; 95% CI 1.22, 3.21; p = 0.006) remained 
independently positively associated with sexual risk 
behavior, even after controlling for other IPV dimensions 
(i.e. physical and/or injurious). Furthermore, several back-
ground variables remained significantly positively associ-
ated with sexual risk behavior: crystal meth use (OR 2.27, 
95% CI 1.54, 3.35; p < 0.001), HIV-positive status (OR 
Table 1  RDS-weighted 
estimations and 95% confidence 
intervals (CIs) for IPV 
victimisation and sexual risk 
behaviors among women who 
inject drugs in the Perempuan 
Bersuara study, by survey city
Greater Jakarta (n = 572) Bandung (n = 159)
N Unweighted % RDS-
weighted 
%
95% CI N Unweighted % RDS-
weighted 
%
95% CI
Past-year intimate partner violence (IPV)
 Any type of IPV (psychological, physical/injurious and/or sexual)
  Yes 401 70.1 68.9 65.0, 72.6 91 57.2 55.9 48.0, 63.5
  No 171 29.9 31.1 27.3, 35.0 68 42.8 44.1 36.5, 52.0
 Psychological aggression
  Yes 348 60.8 58.8 54.7, 62.8 87 54.7 52.6 44.7, 60.3
  No 224 39.2 41.2 37.2, 45.3 72 45.3 47.4 39.7, 55.3
 Physical and/or injurious assault
  Yes 250 43.7 38.8 35.0, 42.8 75 47.2 42.2 34.8, 50.0
  No 322 56.3 61.2 57.2, 65.0 84 52.8 57.8 50.0, 65.2
 Sexual coercion
  Yes 192 33.6 39.8 35.7, 44.0 25 15.7 19.6 13.7, 27.3
  No 380 66.4 60.2 56.0, 64.3 134 84.3 80.4 72.7, 86.3
HIV sexual risk behaviors
 Condomless vaginal and/or anal sex at last intercourse
  Yes 353 61.7 65.1 61.1, 68.8 86 54.1 46.9 39.2, 54.8
  No 219 38.3 34.9 31.2, 38.8 73 45.9 53.1 45.2, 60.8
 Sexually transmitted infection (STI) symptomatology (≥ 2 symptoms)
  Yes 287 50.2 52.8 48.6, 56.8 37 23.3 21.2 15.7, 28.1
  No 285 49.8 47.2 43.2, 51.3 122 76.7 78.8 71.9, 84.3
 Number of sex partners (past 12 months)
  ≤ 1 334 58.4 63.8 59.8, 67.6 94 59.1 59.4 51.5, 66.8
  2–5 138 24.1 25.1 21.6, 28.9 60 37.7 37.8 30.5, 45.7
  ≥ 6 100 17.5 11.1 9.2, 13.4 5 3.1 2.8 1.1, 6.6
 Endorsement of one or more of the sexual risk behaviors above
  Yes 447 78.2 76.2 71.4, 80.5 112 70.4 74.1 66.2, 80.6
  No 125 21.8 23.8 19.5, 28.6 47 29.6 25.9 19.4, 33.8
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Table 2  Socio-demographic 
characteristics, IPV, and 
sexual risk behavior among 
women who inject drugs in the 
Perempuan Bersuara study, 
Indonesia, unweighted estimates
Total (N = 731) N %
Socio-demographic and background variables
 Study city
  Greater Jakarta 572 78.2
  West Java 159 21.8
 Age (years)
  ≤ 24 92 12.6
  25–34 473 64.7
  ≥ 35 166 22.7
 Education level (highest completed)
  Junior high school or lower 148 20.2
  High school or higher 583 79.8
 Employment status
  Unemployed 324 44.3
  Employed (full-time, part-time, or contract work) 407 55.7
 Housing status
  Unstable housing/homeless 39 5.3
  Stable housing 692 94.7
 Individual monthly income (in million Indonesian Rupiah, IDR)
  < 3.8 million IDR (approx. 285 USD) 398 54.5
  ≥ 3.8 million IDR (approx. 285 USD) 333 45.5
 Primary source of monthly income (> 50%)
  Intimate partner 186 25.4
  Family/relatives 127 17.4
  Full-time employment 142 19.4
  Casual/contract work 120 16.4
  Trading sex 79 10.8
  Other illicit/illegal activities (i.e., selling drugs, stealing) 77 10.5
 Relationship status
  Currently married 283 38.7
  Not currently married 448 61.3
 Dependent children
  Yes 413 56.5
  No 318 43.5
 Type of drug injected (previous 12 months)
  Heroin 690 94.4
  Buprenorphine 140 19.2
  Pharmaceuticalsa 29 4.0
  Crystal methaphetamine 6 0.8
 Type of drug non-injected (previous 12 months)
  Heroin 686 93.8
  Crystal methamphetamine 491 67.2
  Pharmaceuticalsa 338 46.2
  Cannabis 265 36.3
  Ketamine 48 6.6
 Self-reported HIV serostatus
  Reactive 341 46.7
  Non-reactive 243 33.2
  Unknown 147 20.1
Intimate partner violence (IPV) in the previous year
 Any type of IPV (psychological, physical/injurious and/or sexual)
  Yes 492 67.3
3315AIDS and Behavior (2018) 22:3307–3323 
1 3
1.70, 95% CI 1.15, 2.50; p = 0.007), and lower than high 
school educational attainment (OR 2.53, 95% CI 1.43, 
4.50; p = 0.002). Two covariates were negatively associ-
ated with engaging in sexual risk behavior: age (OR 0.96, 
95% CI 0.92, 1.00; p = 0.040), and marital status (OR 0.50, 
95% CI 0.33, 0.76; p = 0.001).
Additive Effects
The predicted probabilities of the outcome when exposed 
to co-occurring forms of IPV victimization are displayed 
in Fig. 1. Strong additive effects were shown on wom-
en’s sexual risk behavior. The prevalence of sexual risk 
behavior was 64.1% among women who did not experi-
ence any form of past-year IPV. Among women exposed 
to any one of psychological, physical and/or injurious, or 
sexual IPV, 72.4–76.9% reported engaging in sexual risk 
behavior. Among women experiencing two co-occurring 
forms of IPV, levels of sexual risk behavior increased to 
82.3–85.6%. With polyvictimization of all three forms of 
IPV, the percentage of women reporting sexual risk behav-
ior escalated to 89.9%.
Discussion
Findings from this study suggest that, when considered sep-
arately, psychological, physical, and sexual dimensions of 
IPV each has significant effects on sexual risk among women 
who inject drugs in Indonesia. This study found that at least 
6 in 10 women who inject drugs were exposed to some form 
of past-year IPV, which is up to 24 times higher than IPV 
prevalence found in the general Indonesian female popula-
tion [67]. Approximately three quarters of women across the 
two study cities engaged in HIV sexual risk behavior. It is 
especially concerning that nearly half of the women had STI 
symptoms, since the presence of STIs increases the infec-
tiousness of HIV and facilitates HIV transmission [68, 69]. 
Furthermore, more than one third of women had multiple 
sexual partners, yet only 36.7% reported using a condom at 
last sex. These figures suggest a gendered vulnerability and 
risk: by comparison, among a national sample of mostly 
male injecting drug users in Indonesia, 51.6% reported using 
a condom at last sex [18]. Together, these findings highlight 
drug-using women’s considerable risk for contracting HIV 
and onwards transmission to their sexual and injecting part-
ners, and perinatally to infants. For these urban, low-income 
Table 2  (continued) Total (N = 731) N %
  No 239 32.7
 Psychological aggression
  Yes 435 59.5
  No 296 40.5
 Physical and/or injurious assault
  Yes 325 44.5
  No 406 55.5
 Sexual coercion
  Yes 217 29.7
  No 514 70.3
Sexual risk behavior
 Unprotected vaginal or anal sex at last intercourse
  Yes 439 60.1
  No 292 39.9
 Sexually transmitted infection (STI) symptomatology (≥ 2)
  Yes 324 44.3
  No 407 55.7
 Number of sex partners (past 12 months)
  ≤ 1 428 58.6
  2–5 198 27.1
  ≥ 6 105 14.4
 Endorsement of one or more of the sexual risk indices above
  Yes 559 76.5
  No 172 23.5
a Pharmaceuticals include benzodiazepines (e.g., diazepam) and opiate-based medication (e.g., codeine, 
tramadol) used without a prescription
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women, IPV victimization could result in increased engage-
ment in risky sexual behavior, and therefore in increased 
vulnerability to HIV. This risk was magnified by 26% when 
psychological, physical and/or injurious, and sexual forms 
of IPV co-occurred.
The finding that IPV is associated with sexual risk behav-
ior is consistent with results from previous studies [8, 51, 
70]. This association may be explained by women’s lim-
ited capacity to negotiate safer behaviours, particularly in 
abusive relationships. For instance, research with women 
in methadone treatment in the U.S. found that women who 
insisted that a partner use condoms were at elevated risk of 
IPV victimization, since partners tended to perceive such 
requests as a breach of gender role expectations, lack of 
trust, sign of infidelity or a threat to male dominance in the 
relationship. In the Indonesian context, fear of escalating 
partner aggression may lead some women to acquiesce to 
condomless sex and other risky behaviors, as has been sub-
stantiated by qualitative research with women who inject 
drugs in Central Java [25]. The link between experiencing 
IPV and elevated sexual risk-taking in Indonesia may be fur-
ther shaped by social stigma, cultural norms and relationship 
power differentials [23]. Gendered cultural beliefs around 
placing care for an intimate partner above oneself, avoid-
ing conflict, and preserving harmony in relationships may 
contribute to women’s inability to negotiate safer sex, even 
in situations when they feel they are at risk [23, 71]. Such 
gendered dynamics may also extend to the link between 
IPV and having multiple sexual partners. Previous studies 
have shown that the traumatic and economic consequences 
of being in an abusive relationship may steer women into 
other types of relationships, including survival sex work [8, 
41, 46]. Women in intimate partnerships with drug-using 
partners may feel added pressure to trade sex and engage 
in risky encounters in order to maintain both their and their 
partners’ drug supply and to provide for their families [46, 
72]. In the Indonesian context, this may include the practice 
of turbo (tukar body), or trading sex with drug dealers in 
exchange for drugs. This practice is common among low-
income, drug-using women and may be enforced by wom-
en’s partners as part of a gendered division of labour [19].
Crucially, psychological and sexual IPV victimization 
remained independently associated with HIV risk-taking 
behavior after controlling for other dimensions of IPV. This 
finding contributes to an emerging body of research show-
ing that psychological aggression exerts comparable effects 
to physical and/or sexual forms of IPV [11]. A reduction in 
effect estimates was observed when all forms of IPV were 
included in the model, which could reflect any of the fol-
lowing: collinearity, confounding, or mediating relationships 
between the variables assessed. Given the small VIF scores 
detected for the model, overall collinearity is unlikely to 
have impacted the effect estimates. However, confounding 
through additional variables cannot be fully ruled out in 
cross sectional study analyses such as this one [63]. Two-
way interactions were assessed between all model variables 
and none were found. We can speculate about potential 
mediating relationships in light of past research. Women’s 
crystal meth use may mediate the complex relationship 
between experiencing IPV and HIV risk, as using different 
types of drugs, including stimulants, has been associated 
with both violence victimization and unsafe sexual practices 
[51, 73, 74]. The association between IPV and HIV risk may 
be further mediated by women’s low socio-economic status, 
which could drive women to use drugs and trade sex in peril-
ous environments where coercive sex is common and safe 
sexual practices are challenging to negotiate [75]. Further-
more, there is strong evidence for the role of mental health, 
particularly depression and post-traumatic stress disorder, in 
Table 3  Bivariate associations between IPV, sociodemographic and 
background variables, and sexual risk behavior among women who 
inject drugs in the Perempuan Bersuara study, Indonesia
95% CI 95% confidence intervals; ORs odds ratios
Independent variables Dependent variable: engaged 
in sexual risk behavior 
(n = 559)
ORs 95% CIs p value
Psychological aggression (ref. no)
 Yes 2.92 2.06, 4.16 ≤ 0.001
Physical and/or injurious assault (ref. no)
 Yes 2.73 1.87, 3.98 ≤ 0.001
Sexual coercion (ref. no)
 Yes 2.38 1.55, 3.66 ≤ 0.001
Non-injection crystal methamphetamine use (ref. no)
 Yes 2.47 1.74, 3.51 ≤ 0.001
Self-reported HIV status (ref. negative/unknown)
 Positive 1.37 0.97, 1.94 0.074
Survey city (ref. Bandung, West Java)
 Greater Jakarta 1.50 1.01, 2.23 0.044
 Age (years) 0.95 0.91, 0.98 0.002
Education level (ref. high school and/or higher)
 Junior high school or lower 2.59 1.53, 4.39 ≤ 0.001
Housing status (ref. stable housing)
 Unstable housing/homeless 3.88 1.18, 12.75 0.026
Employment status (ref. employed)
 Unemployed 0.89 0.63, 1.26 0.509
Individual monthly income (ref. ≥ 3.8 mill IDR)
 < 3.8 mill IDR (approx. 285 USD) 1.07 0.76, 1.52 0.680
Financial dependency (ref. no)
 Yes 1.03 0.70, 1.53 0.878
Relationship status (ref. not currently married)
 Currently married 0.74 0.53, 1.05 0.093
Dependent children or other dependents (ref. no)
 Yes 1.21 0.86, 1.70 0.278
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Table 4  Multivariate 
associations between IPV, 
sociodemographic and 
background factors and HIV 
sexual risk behavior among 
women who inject drugs in the 
Perempuan Bersuara study, 
Indonesia
Independent variables Dependent variable: engaged in sexual 
risk behavior (n = 559)
ORs 95% CIs p-value
Model  1a
 Past-year psychological aggression (ref. no)
  Yes 2.77 1.91, 4.03 ≤ 0.001
 Non-injection crystal methamphetamine use (ref. no)
  Yes 2.26 1.54, 3.33 ≤ 0.001
 HIV serostatus (ref. non-reactive/unknown)
  Reactive 1.72 1.18, 2.53 0.005
  Age (years) 0.96 0.92, 0.99 0.023
 Education level (ref. high school and/or higher)
  Junior high school or lower 2.50 1.42, 4.41 0.002
 Housing status (ref. stable housing)
  Unstable housing/homeless 1.80 0.53, 6.19 0.349
 Relationship status (ref. not currently married)
  Currently married 0.54 0.36, 0.81 0.003
 Survey city (ref. Bandung, West Java)
  Greater Jakarta 1.32 0.82, 2.12 0.249
Model  2b
 Past-year physical and/or injurious assault (ref. no)
  Yes 2.49 1.67, 3.70 ≤ 0.001
 Non-injection crystal methamphetamine use (ref. no)
  Yes 2.30 1.57, 3.37 ≤ 0.001
 HIV serostatus (ref. non-reactive/unknown)
  Reactive 1.65 1.13, 2.42 0.010
  Age (years) 0.96 0.92, 0.99 0.022
 Education level (ref. high school and/or higher)
  Junior high school or lower 2.46 1.40, 4.34 0.002
 Housing status (ref. stable housing)
  Unstable housing/homeless 1.71 0.50, 5.86 0.392
 Relationship status (ref. not currently married)
  Currently married 0.58 0.38, 0.86 0.007
 Survey city (ref. Bandung, West Java)
  Greater Jakarta 1.39 0.87, 2.24 0.169
Model  3c
 Past-year sexual coercion (ref. no)
  Yes 2.61 1.65, 4.13 ≤ 0.001
 Non-injection crystal methamphetamine use (ref. no)
  Yes 2.43 1.66, 3.55 ≤ 0.001
 HIV serostatus (ref. non-reactive/unknown)
  Reactive 1.80 1.23, 2.63 0.002
  Age (years) 0.96 0.92, 0.99 0.024
 Education level (ref. high school and/or higher)
  Junior high school or lower 2.65 1.50, 4.67 0.001
 Housing status (ref. stable housing)
  Unstable housing/homeless 2.88 0.85, 9.77 0.090
 Relationship status (ref. not currently married)
  Currently married 0.56 0.38, 0.84 0.005
 Survey city (ref. Bandung, West Java)
  Greater Jakarta 1.11 0.69, 1.77 0.664
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both perpetuating and mediating relationships between sub-
stance use, IPV, and HIV [76–78]. Mental health challenges 
can also play a role in increasing women’s substance use and 
in inhibiting their ability to discern and navigate risky situ-
ations [79]. Future research among women who use drugs 
in low- and middle-income settings has the opportunity to 
explore these and other potential mediating mechanisms 
which are associated with both IPV and HIV risk outcomes.
Moreover, our findings show that crystal meth use dou-
bled the odds of engaging in sexual risk behavior. This find-
ing confirms previous research from North America [55, 
80] and contributes to a nascent body of evidence on the 
link between non-injection crystal meth use and elevated 
HIV transmission risk in Indonesia [81]. This finding is 
particularly alarming considering that Indonesia has seen a 
surge in crystal meth use in recent years [82], which may be 
contributing to an increase in overall HIV prevalence rates. 
Existing HIV prevention interventions for women who inject 
drugs in Indonesia should therefore be adapted to better meet 
the needs of poly-drug and crystal meth users.
Furthermore, HIV-positive status was associated with 
greater sexual risk-taking. Previous research with inject-
ing populations has been inconclusive on the relationship 
between HIV sero-positivity and sexual risk, with studies 
finding both positive [83] and negative [84] associations. 
Our findings suggest that effective prevention of HIV among 
women who inject drugs and their intimate partners in 
Indonesia may benefit from including enhanced prevention 
efforts focusing on substance-using women who live with 
HIV.
In addition, younger women and women with a lower 
level of education were more likely to engage in sexual 
risk behavior. These findings support research from the 
U.S. suggesting that women’s educational and social dis-
advantage places them at higher risk of HIV transmission 
[5, 85]. Women’s education level plays an important role in 
95% CI 95% confidence intervals, ORs odds ratios
a Model 1 includes past-year psychological aggression, controlling for past-year crystal methamphetamine 
use, self-reported HIV status, age, education level, relationship status, housing status, and survey city
b Model 2 includes physical and/or injurious assault, controlling for past-year crystal methamphetamine 
use, self-reported HIV status, age, education level, relationship status, housing status, and survey city
c Model 3 includes sexual coercion, controlling for past-year crystal methamphetamine use, self-reported 
HIV status, age, education level, relationship status, housing status, and survey city
d Model 4 includes all IPV dimensions (psychological, physical and/or injurious, sexual) in the same model, 
controlling for past-year crystal methamphetamine use, self-reported HIV status, age, education level, rela-
tionship status, housing status, and survey city. Cox-Snell  R2 = 0.133; Nagelkerke  R2 = 0.200
Table 4  (continued) Independent variables Dependent variable: engaged in sexual 
risk behavior (n = 559)
ORs 95% CIs p-value
Model  4d
 Past-year psychological aggression (ref. no)
  Yes 1.87 1.17, 2.99 0.009
 Past-year physical and/or injurious assault (ref. no)
  Yes 1.53 0.93, 2.50 0.093
 Past-year sexual coercion (ref. no)
  Yes 1.98 1.22, 3.21 0.006
 Non-injection crystal methamphetamine use (ref. no)
  Yes 2.27 1.54, 3.35 ≤ 0.001
 Self-reported HIV status (ref. non-reactive/unknown)
  Reactive 1.70 1.15, 2.50 0.007
  Age (years) 0.96 0.92, 1.00 0.040
 Education level (ref. high school and/or higher)
  Junior high school or lower 2.53 1.43, 4.50 0.002
 Housing status (ref. stable housing)
  Unstable housing/homeless 1.95 0.56, 6.78 0.293
 Relationship status (ref. not currently married)
  Currently married 0.50 0.33, 0.76 0.001
 Survey city (ref. Bandung, West Java)
  Greater Jakarta 1.23 0.76, 2.00 0.400
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perpetuating high-risk situations and gender power imbal-
ances [85], which may be intensified in abusive and drug-
involved relationships. Our finding that married women were 
less likely than their non-married counterparts to engage in 
sexual risk behavior is at odds with previous research in one 
regard. Specifically, studies have suggested that women in 
steady relationships, including those with high-risk partners, 
are more likely to engage in risky sex than those in casual or 
transactional partnerships [8].
The findings in this paper suggest that IPV could also 
influence other HIV-related health outcomes and merits fur-
ther investigation in Asia and other regions with injection-
driven epidemics. For instance, the same mechanisms that 
heighten the risk of contracting sexually-transmitted HIV 
appear to also elevate women’s injecting risk (i.e. syringe 
sharing and borrowing) and should be considered in future 
analyses [86, 87]. Furthermore, emerging research among 
drug-using women in Malaysia points to the adverse effects 
of IPV, co-occurring mental health challenges, and low 
social support on HIV testing and/or monitoring outcomes 
[53]. In the context of accumulating research on the det-
rimental effect of overlapping syndemics in perpetuating 
health-related disparities among women who use drugs [5], 
future research with drug-using women in Indonesia may 
benefit from investigating associations and mechanisms 
linking IPV with a broader range of HIV risk and treatment 
outcomes such as viral load, enrolment, and adherence to 
antiretroviral treatment.
The results of this study should be considered in the con-
text of several limitations. First, the cross-sectional design 
prohibits assessing causality, highlighting the need for fol-
low-up research employing longitudinal designs. Second, 
the use of self-report may be subject to recall and report-
ing bias, including the tendency to under-report stigma-
tised behaviors [88]. Longer recall periods (e.g. lifetime, 
past year) carry a higher risk of erroneous reporting than 
measures requiring shorter recall periods (e.g. past week, 
month, or three months). Thus, the findings are vulnerable 
to potential biases related to recall bias around sexual and 
injecting behaviors, which were assessed for the preceding 
12 months. This limitation was minimised through the use 
of a peer recruitment strategy [89] shown to enhance the 
validity and reliability of data by improving rapport and trust 
and enabling participants to provide more honest responses 
[90]. Third, findings should be carefully interpreted in light 
of potential biases associated with RDS analytical meth-
ods. Since RDS depends on social networks for referral, 
some sub-populations of drug-using women (i.e. women 
injecting only with one partner) might be underrepresented 
in this sample due to having limited networks within the 
broader population. Furthermore, because RDS recruitment 
starts with purposively selected seeds that may or may not 
accurately represent the underlying network structure of the 
population, there is a risk that the resulting sample may be 
more representative of the characteristics of the seeds rather 
than the those of the target population, resulting in a form of 
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Fig. 1  Marginal effects model testing for additive effects of different 
forms of intimate partner violence on sexual risk behaviour among 
women who inject drugs. Controls for self-reported HIV status, non-
injection crystal methamphetamine use, age, relationship status, edu-
cation level, housing status, and survey city
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selection bias [91]. We attempted to minimize the potential 
impact of seed selection on the estimates by monitoring con-
vergence plots for key variables throughout data collection to 
see whether the estimates appeared to stabilize with succes-
sive waves of recruitment. Given that recruitment chains at 
both study sites converged to a sampling equilibrium well in 
advance of attaining the full sample size, we concluded that 
bias associated with the non-random recruitment of seeds 
was substantially eliminated. We paid particular attention 
to monitoring recruitment chains in Bandung, where only 
two seeds generated 100% of the sample size in that city 
and nearly 22% of the cumulative sample across the two 
study sites. The recruitment chains were long enough to 
ensure that there was no correlation of characteristics to the 
seed with the outcome of recruitment, and the recruitment 
process penetrated deeply into the population of women 
who inject drugs in Bandung. In addition, there was no evi-
dence of differential recruitment activity as observed by low 
homophily scores and minimal differences in mean personal 
degrees for all variables of interest, indicating that lingering 
bias associated with seed dependence was unlikely to affect 
the estimates. Finally, a key theoretical assumption in RDS 
is that each sample comprises a single network component 
[60]. Although RDS-adjusted estimates were reported sepa-
rately for each city, multivariate analyses were performed 
on the combined, unweighted dataset in order to retain the 
power and precision corresponding to the original calculated 
sample size. Therefore, while the city-level prevalence esti-
mates fulfilled RDS theoretical assumptions, findings from 
the regression and marginal effects analyses may not be gen-
eralizable to other settings.
Notwithstanding these limitations, the data presented here 
constitute the best currently available evidence on correlates 
of HIV sexual risk behavior in a diverse sample of Indone-
sian women who inject drugs. This study has important pro-
grammatic implications. Our findings provide new insights 
into the sexual risk associations of different forms of IPV 
among women who inject drugs in Asia. Longitudinal data 
are needed to test the temporal relationships of associations 
observed in this study, and assess potential causal mecha-
nisms to be subsequently addressed through intervention 
research. Such analyses would be the next step to informing 
evidence-based interventions and service provision. As a 
first step, IPV prevention and screening targeting women 
who use drugs in Indonesia should be integrated within 
existing HIV prevention and harm reduction programs. 
Possible settings for service integration include methadone 
maintenance clinics, community health centers providing 
HIV prevention services, and community-based drug treat-
ment facilities. Ultimately, this study’s findings demonstrate 
an urgent need for the optimization of HIV prevention inter-
ventions to better respond to the high prevalence of IPV and 
HIV risk among Indonesian women who inject drugs.
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